Cognetivity Neurosciences 

$0.01
2
+$0+0% 今天

统计数据

当日最高
0
当日最低
0
52周最高
0.14
52周最低
0
成交量
1,000
平均成交量
24,616
市值
686,874
市盈率
-
股息收益率
-
股息
-

收益

16Dec预期
Q3 2020
Q1 2021
Q2 2021
Q3 2021
Q1 2022
Q2 2022
Q3 2022
-0.08
-0.06
-0.03
-0.01
预期每股收益
N/A
实际每股收益
-0.017

人们还关注

此列表基于关注CGNSF的Stock Events用户的观察列表。这不是投资建议。

竞争者

这个列表是基于最近市场事件的分析。这不是投资建议。

关于

Biotechnology
Health Technology
Cognetivity Neurosciences Ltd. operates as a healthcare company. It develops an integrated cognitive assessment, a cognitive testing platform for use in medical, commercial, and consumer environments that helps to detect the earliest signs of impairment by testing the performance of large areas of the brain to support the diagnosis of dementia; and offers OptiMind, a wellness app. The company was formerly known as Utor Capital Corp. and changed its name to Cognetivity Neurosciences Ltd. in December 2017. Cognetivity Neurosciences Ltd. was incorporated in 2015 and is headquartered in Vancouver, Canada.
Show more...
首席执行官
员工
2500
国家
CA
ISIN
CA19243C1005

上市公司